Prospect News: News for Paratek Pharmaceuticals Inc.

E-mail us: service@prospectnews.com Or call: 212 374 2800

Bank Loans - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products

Add to balance / Manage account

Not logged in

Prospect News home > Main news index > All issuers starting with P > Issuers starting with P, PP only > All stories on Paratek Pharmaceuticals Inc. > Stories on Paratek Pharmaceuticals Inc., PP only

Search again

Enter part or all of the issuer name:

Market:

All markets No structured products Bank loans Canadian bonds CLOs Convertibles Distressed debt Emerging markets High yield Investment grade Liability management Municipals PIPEs Preferreds Private placements All leveraged markets Structured products

Market: BK = Bank loans, CV = Convertibles, DD = Distressed Debt, EM = Emerging Markets, HY = High Yield, IG = Investment Grade, LM = Liability Management, MU = Municipals, PP = PIPEs, PF = Preferreds, PV = Private Placements, SP = Structured Products
Recent items, highlighted in orange, are $4.00 each. All others are $1.00 each. Headlines in gray are not currently covered by your subscription.

Paratek Pharmaceuticals Inc.

6/27/2016	PP	Paratek greenshoe exercised for $63.54 million public sale of stock
6/22/2016	PP	Paratek prices a $55.25 million public sale of common stock at $13.00
6/20/2016	PP	Paratek plans to price public offering of 3.75 million common shares
10/15/2015	PP	Paratek could raise $50 million through at-the-market equity offering
10/5/2015	PP	Paratek plans to raise $41 million through loan, equity sale agreement
5/5/2015	PP	Paratek greenshoe exercised in $75.68 million public offering of stock
4/30/2015	PP	Paratek Pharmaceuticals prices upsized $70 million public sale of stock
4/27/2015	PP	Paratek Pharmaceuticals plans $60 million public offering of its stock
9/27/2012	PP	Paratek Pharmaceuticals aims to price initial public offering of stock

©2025 Prospect News. This page is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies, faxing, photocopying or any other form of reproduction.